Inhibition of Pim1 kinase reduces viral replication in primary bronchial epithelial cells

European Respiratory Journal

Volumn 45, Issue 6, 2015, Pages 1745-1748

  De Vries, Maaike ^a,b   Smithers, Natalie P ^b   Howarth, Peter H ^c   Nawijn, Martijn C ^a   Davies, Donna E ^b,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CIGARETTE SMOKE; GAMMA INTERFERON; INTERLEUKIN 29; PROTEIN KINASE PIM 1; RANTES; CCL5 PROTEIN, HUMAN; CXCL10 PROTEIN, HUMAN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IL29 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; MESSENGER RNA; PIM1 PROTEIN, HUMAN; VIRUS RNA;

APOPTOSIS; ASTHMA; BRONCHUS MUCOSA; CELL DEATH; CELL SURVIVAL; COPY NUMBER VARIATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS A16; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS CELL INTERACTION; VIRUS PARTICLE; VIRUS RELEASE; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; BRONCHUS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; IN VITRO STUDY; METABOLISM; RHINOVIRUS; VIROLOGY; VIRUS LOAD;

APOPTOSIS; BRONCHI; CELLS, CULTURED; CHEMOKINE CCL5; CHEMOKINE CXCL10; EPITHELIAL CELLS; HUMANS; IN VITRO TECHNIQUES; INTERFERON-BETA; INTERLEUKINS; PROTO-ONCOGENE PROTEINS C-PIM-1; RHINOVIRUS; RNA, MESSENGER; RNA, VIRAL; VIRAL LOAD; VIRUS REPLICATION;

EID: 84930395940     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00206514     Document Type: Letter

References (13)

1. Jackson DJ, Sykes A, Mallia P, et al. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 2011; 128: 1165-1174.
2. O'Byrne PM. Therapeutic strategies to reduce asthma exacerbations. J Allergy Clin Immunol 2011; 128: 257-263.
3. Cakebread JA, Xu Y, Grainge C, et al. Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus. J Allergy Clin Immunol 2011; 127: 1148-1154.
4. Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005; 201: 937-947.
5. Pogacic V, Bullock AN, Fedorov O, et al. Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity. Cancer Res 2007; 67: 6916-6924.
6. Macdonald A, Campbell DG, Toth R, et al. Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL. BMC Cell Biol 2006; 7: 1.
7. Nawijn MC, Alendar A, Berns A. For better or for worse: the role of Pim oncogenes in tumorigenesis. Nat Rev Cancer 2011; 11: 23-34.
8. de Vries M, Heijink IH, Gras R, et al. Pim1 kinase protects airway epithelial cells from cigarette smoke-induced damage and airway inflammation. Am J Physiol Lung Cell Mol Physiol 2014; 307: L240-L251.
9. Lin YW, Beharry ZM, Hill EG, et al. A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma. Blood 2010; 115: 824-833.
10. Khaitov MR, Laza-Stanca V, Edwards MR, et al. Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy 2009; 64: 375-386.
11. Hillyer P, Male D. Expression of chemokines on the surface of different human endothelia. Immunol Cell Biol 2005; 83: 375-382.
12. Takaoka A, Hayakawa S, Yanai H, et al. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 2003; 424: 516-523.
13. Spurrell JC, Wiehler S, Zaheer RS, et al. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 2005; 289: L85-L95.